FRANKLIN LAKES, N.J., Nov. 7, 2012 /PRNewswire/ -- BD (Becton, Dickinson and Company) (BDX), a leading global medical technology company, today reported quarterly revenues of $1.967 billion for the fourth fiscal quarter ended September 30, 2012, representing a decrease of 1.1 percent from the prior-year period, or an increase of 4.7 percent on a foreign currency-neutral basis.
